[go: up one dir, main page]

NZ609720A - A pharmaceutical composition with improved storage stability - Google Patents

A pharmaceutical composition with improved storage stability

Info

Publication number
NZ609720A
NZ609720A NZ609720A NZ60972011A NZ609720A NZ 609720 A NZ609720 A NZ 609720A NZ 609720 A NZ609720 A NZ 609720A NZ 60972011 A NZ60972011 A NZ 60972011A NZ 609720 A NZ609720 A NZ 609720A
Authority
NZ
New Zealand
Prior art keywords
oxytocin
pharmaceutical composition
treatment
storage stability
improved storage
Prior art date
Application number
NZ609720A
Inventor
Anders Nilsson
Mattias Malm
Kazimierz Wisniewski
Britta Siekmann
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of NZ609720A publication Critical patent/NZ609720A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Disclosed herein is a liquid composition comprising: an oxytocin agonist and/or an oxytocin analogue or salt thereof; and an anti-oxidant; wherein the pH of the composition is from 5.0 to 6.0, for use in the treatment of uterine atony, for example following vaginal delivery of the infant, delivery of the infant by Caesarean section, or for use in the treatment or prevention of uterine atony in a patient who is at risk of developing PPH; and/or for use in the treatment or prevention of excessive bleeding following vaginal delivery. Preferably the oxytocin agonist and/or an oxytocin analogue is 1-deamino-8-D-arginine vasopressin (Desmopressin).
NZ609720A 2010-09-30 2011-09-29 A pharmaceutical composition with improved storage stability NZ609720A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10251690 2010-09-30
NZ60816311 2011-09-29

Publications (1)

Publication Number Publication Date
NZ609720A true NZ609720A (en) 2014-12-24

Family

ID=52464981

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ609720A NZ609720A (en) 2010-09-30 2011-09-29 A pharmaceutical composition with improved storage stability

Country Status (1)

Country Link
NZ (1) NZ609720A (en)

Similar Documents

Publication Publication Date Title
NZ609719A (en) Pharmaceutical composition
PH12017501306A1 (en) Inhibitors of histone demethylases
IN2012MN02923A (en)
IN2015DN01156A (en)
MX2010009447A (en) Use of lhrh antagonists at non-castrating doses.
PH12015501964B1 (en) Substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c
AR092661A1 (en) REINFORCED KINASE INHIBITOR DURING TRANSFECTION (RET) AND A METHOD FOR IDENTIFYING A SENSITIVE PATIENT TO A COMPOSITE REPRESENTED BY FORMULA (1)
MX2019003467A (en) Formulations and methods for vaginal delivery of antiprogestins.
EA201500851A1 (en) ESTRA-1,3,5 (10), 16-TETRAEN-3-CARBOXAMIDES TO INHIBIT 17β-HYDROXYSTEROID DEGYDROGENASE (AKR1C3)
PH12012501402A1 (en) Aqueous solution comprising 3-quinuclidinones for the treatment hyperproliferative, autoimmune and heart disease
AR086395A1 (en) PACKAGE FOR TREATMENT OF PATHOLOGIES
UA113966C2 (en) WATER LIQUID PHARMACEUTICAL COMPOSITION CONTAINING ARBECACIN
MX2013014849A (en) Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia.
HRP20211696T1 (en) Process for the manufacture of fluorinated olefins
NZ609720A (en) A pharmaceutical composition with improved storage stability
EA201591095A1 (en) PROTEIN SLURP-1 FOR USE IN THE TREATMENT OF EYE DISEASES
MX2015008171A (en) Formulation comprising amorphous agomelatine.
RU2012129115A (en) METHOD FOR TREATING ACUTE POST-PERMANENT ENDOMETRITIS IN COWS
PH12013501896A1 (en) Use of a sprayable composition comprising ambroxol
MX359106B (en) INJECTABLE PHARMACEUTICAL COMPOSITION OF DEXKETOPROFEN and TRAMADOL.
ES2422563A1 (en) Injectable pharmaceutical composition of ibuprofen and arginine, its preparation procedure, unit dosage form and use thereof (Machine-translation by Google Translate, not legally binding)
NZ608164A (en) Formulations for bovine granulocyte colony stimulating factor and variants thereof
EP2563785A4 (en) Compounds as agonists of s1p1 receptors
EA201290972A1 (en) WAYS TO REDUCE SYMPTOMS IN SUBJECTS WITH THE APPLICATION OF MEDICINAL FORMS FOR SINGLE INTRODUCTION WITH GRADUALLY DECREASING RELATIONS
UA96878C2 (en) Means for treatment of cardiovascular diseases and regulation of metabolic processes

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 29 SEP 2016 BY CPA GLOBAL

Effective date: 20150815

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 29 SEP 2017 BY CPA GLOBAL

Effective date: 20160819

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 29 SEP 2018 BY CPA GLOBAL

Effective date: 20170817

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 29 SEP 2019 BY JAMES + WELLS

Effective date: 20180928

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 29 SEP 2020 BY IPAN GMBH

Effective date: 20190918

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 29 SEP 2021 BY IPAN GMBH

Effective date: 20200915

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 29 SEP 2022 BY IPAN GMBH

Effective date: 20210915

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 29 SEP 2023 BY IPAN GMBH

Effective date: 20220915

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 29 SEP 2024 BY IPAN GMBH

Effective date: 20230915

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 29 SEP 2025 BY IPAN GMBH

Effective date: 20240916